A Trial Testing Amiodarone in Chagas Cardiomiopathy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03193749

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Fundación Cardioinfantil Instituto de Cardiología (from the registry)
Registry
  • NCT NCT03193749
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Colombia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03193749. Randomized; quadruple masking; primary purpose treatment. Start 2017-06-12 (actual); primary completion 2020-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial Testing Amiodarone in Chagas Cardiomiopathy
Acronym
ATTACH
Condition
Chagas Cardiomyopathy
Intervention (Drug)
Amiodarone Hydrochloride
Intervention (Drug)
Placebo Oral Tablet
Lead sponsor
Fundación Cardioinfantil Instituto de Cardiología (class: other)
Collaborator
Instituto de Corazón de Bucaramanga (class: not stated)

Record details

Record id
cardio:ct-nct03193749
Content hash
a998af19fe1d54f1a7499d4a2b5b6d434e643f3bf7a6965ebd526afb3dd41fab